Kiso Y - Search Results

1

A reductive acidolysis final deprotection strategy in solid phase peptide synthesis based on safety-catch protection.

Kimura T, Fukui T, Tanaka S, Akaji K, Kiso Y. Kimura T, et al. Among authors: kiso y. Chem Pharm Bull (Tokyo). 1997 Jan;45(1):18-26. doi: 10.1248/cpb.45.18. Chem Pharm Bull (Tokyo). 1997. PMID: 9023966

2

Synthesis of rat brain natriuretic peptide 45 using tetrafluoroboric acid deprotection and silyl chloride disulfide formation.

Akaji K, Nakagawa Y, Fujiwara Y, Fujino K, Kiso Y. Akaji K, et al. Among authors: kiso y. Chem Pharm Bull (Tokyo). 1993 Jul;41(7):1244-8. doi: 10.1248/cpb.41.1244. Chem Pharm Bull (Tokyo). 1993. PMID: 8374994

3

Synthesis of human C-type natriuretic peptide 22 using chlorotrityl resin and tetrafluoroboric acid deprotection.

Fujiwara Y, Yokotani J, Akaji K, Kiso Y. Fujiwara Y, et al. Among authors: kiso y. Chem Pharm Bull (Tokyo). 1996 Jul;44(7):1326-31. doi: 10.1248/cpb.44.1326. Chem Pharm Bull (Tokyo). 1996. PMID: 8706139

4

Efficient solid phase peptide synthesis. Use of methanesulfonic acid alpha-amino deprotecting procedure and new coupling reagent, 2-(benzotriazol-1-yl)oxy-1,3-dimethylimidazolidinium hexafluorophosphate (BOI).

Kiso Y, Fujiwara Y, Kimura T, Nishitani A, Akaji K. Kiso Y, et al. Int J Pept Protein Res. 1992 Sep-Oct;40(3-4):308-14. Int J Pept Protein Res. 1992. PMID: 1335997

5

Kynostatin (KNI)-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine.

Mimoto T, Imai J, Kisanuki S, Enomoto H, Hattori N, Akaji K, Kiso Y. Mimoto T, et al. Among authors: kiso y. Chem Pharm Bull (Tokyo). 1992 Aug;40(8):2251-3. doi: 10.1248/cpb.40.2251. Chem Pharm Bull (Tokyo). 1992. PMID: 1423795

6

A synthetic method suitable for the rapid preparation of 13N-labeled dermorphin analogue, H-Tyr-D-Met(O)-Phe-Gly-NH2 (SD-62).

Kiso Y, Iinuma S, Mimoto T, Saji H, Yokoyama A, Akaji K. Kiso Y, et al. Chem Pharm Bull (Tokyo). 1991 Oct;39(10):2734-6. doi: 10.1248/cpb.39.2734. Chem Pharm Bull (Tokyo). 1991. PMID: 1687212

7

New hydroxyl protecting groups of a safety-catch type removable by reductive acidolysis.

Kiso Y, Tanaka S, Kimura T, Itoh H, Akaji K. Kiso Y, et al. Chem Pharm Bull (Tokyo). 1991 Nov;39(11):3097-9. doi: 10.1248/cpb.39.3097. Chem Pharm Bull (Tokyo). 1991. PMID: 1724744

8

KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic.

Mimoto T, Imai J, Tanaka S, Hattori N, Kisanuki S, Akaji K, Kiso Y. Mimoto T, et al. Among authors: kiso y. Chem Pharm Bull (Tokyo). 1991 Nov;39(11):3088-90. doi: 10.1248/cpb.39.3088. Chem Pharm Bull (Tokyo). 1991. PMID: 1799953

9

Solution-phase synthesis of alpha-human atrial natriuretic peptide (alpha-hANP).

Yoshida M, Shimokura M, Fujiwara Y, Fujisaki T, Akaji K, Kiso Y. Yoshida M, et al. Among authors: kiso y. Chem Pharm Bull (Tokyo). 1990 Feb;38(2):382-8. doi: 10.1248/cpb.38.382. Chem Pharm Bull (Tokyo). 1990. PMID: 2140075

10

Solution-phase synthesis of alpha-rat atrial natriuretic peptide (alpha-rANP).

Yoshida M, Shimokura M, Fujiwara Y, Fujisaki T, Akaji K, Kiso Y. Yoshida M, et al. Among authors: kiso y. Chem Pharm Bull (Tokyo). 1990 Apr;38(4):1072-4. doi: 10.1248/cpb.38.1072. Chem Pharm Bull (Tokyo). 1990. PMID: 2143106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

575 results

Search Page

Filters